Predictors of in-hospital mortality in patients with left ventricular assist device
ConclusionsCF-LVADs have not reduced mortality, possibly due to utilization in patients with comorbid conditions. Future trials are necessary for improved patient selection and reduced post-procedural complications.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Atrial Fibrillation | Biomedical Science | Cardiology | Dialysis | Gastroenterology | General Medicine | Heart | Heart Failure | Hemodialysis | Ireland Health | Liver | Liver Disease | Science | Septic Shock | Urology & Nephrology